Icosavax plans to file IND submission and initiate a Phase 1 trial for IVX-A1

MLA

“Icosavax Plans to File IND Submission and Initiate a Phase 1 Trial for IVX-A1.” The Fly, June 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.708500753&authtype=sso&custid=ns315887.

APA

Icosavax plans to file IND submission and initiate a Phase 1 trial for IVX-A1. (2022, June 28). The Fly.

Chicago

The Fly. 2022. “Icosavax Plans to File IND Submission and Initiate a Phase 1 Trial for IVX-A1,” June 28. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.708500753&authtype=sso&custid=ns315887.